The production of medicines, drugs and components of medicines from Dordoi Dary CJSC is carried out on the territory of the Kyrgyz Republic. Also, the entire main line is located on the territory of the At-Bashi district of the Naryn region of Kyrgyzstan.

We are engaged in the development of medicines, technology transfer of recipes for their specific production and use, manufacturing, packaging and transportation of medicines. The product portfolio is regularly updated and expanded. In the lists below you can familiarize yourself with the main areas of our production.

Monoclonal antibodies for the treatment of cancer:

  • Rituximab
  • Bevacizumab
  • Trastuzumab

 

Clotting factors for the treatment of hemophilia:

  • Semiclotin – INN Eptacog alpha
  • Octoclothin – INN Moroctocog alpha

 

Drugs for the treatment of multiple sclerosis:

  • Interbetin – INN Interferon beta-1b

 

Medicines for the treatment of diabetes mellitus:

  • RinGlar – INN Insulin Glargine

 

Drugs for the prevention and treatment of heart attack and stroke:

  • Revecard – INN Alteplase

 

Drugs for the treatment of orphan diseases:

  • Glucerazim – INN Imiglucerase
  • Elimab – INN Eculizumab

 

Drugs for the treatment of obstructive airway diseases:

  • ​Formisonide (formoterol and budesonide)

 

Rheumatology:

  • Adalira (INN Adalimumab)
    Infliximab